You are here

Recombinetics, Inc.

Company Information
Address
3388 Mike Collins Dr
Eagan, MN 55121-2410
United States


http://www.recombinetics.com

Information

UEI: L99NWZNZ7K57

# of Employees: 31


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. An Inducible Swine Hepatocellular Carcinoma Platform for Enhanced Therapeutic Development

    Amount: $342,154.00

    PROJECT SUMMARY Hepatocellular carcinoma (HCC) is a global health burden ranking as the fourth most common and second deadliest cancer in the world. Effective therapeutic strategies for HCC, especiall ...

    SBIRPhase I2023Department of Health and Human Services National Institutes of Health
  2. Development and Characterization of a Preclinical Swine Model of Osteogenesis Imperfecta

    Amount: $224,773.00

    PROJECT SUMMARY Osteogenesis imperfectaOIalso known asbrittle bone diseaseis a genetic disease in which patients have defects in the formationstructureor strength of their bonescausing them to break e ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  3. A Swine Model of Glioblastoma

    Amount: $299,188.00

    PROJECT SUMMARY GlioblastomaGBMis the most common and aggressive primary brain cancer with limited treatment optionsThe median survival for GBM patients is less thanmonths after diagnosisand tumors re ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  4. Swine model of monogenic diabetes with potential implications for T1D, T2D, and double diabetes

    Amount: $300,000.00

    Diabetes mellitusDMis a metabolic ailment caused by inadequate production or utilization of insulinfeatured by excessive amounts of glucose in the bloodThe incidence of diabetes has been rising global ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  5. Development and Evaluation of a Thrombospondin 2 Deficient Pig as an Improved Source of Biomaterial

    Amount: $398,952.00

    Project Summary Newinnovative biological materialsthat promote healing and prevent thrombosisare in high demand to improve a variety of extracellular matrixECMproducts ranging from wound dressings to ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  6. Modeling Disease in Swine by Transplantation of Gene Targeted Germ Cells

    Amount: $1,997,106.00

    PROJECT SUMMARY Swine are important in biomedical research for the study of human diseases that are poorly recapitulated by rodent speciesfor the development and testing of preclinical therapeutics in ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health
  7. Development of swine model of COPD by integrating genetic and environmental risk factors

    Amount: $398,696.00

    PROJECT SUMMARY lpha antitrypsin AAT deficiency AATD and Chronic Obstructive Pulmonary Disease COPD are lung diseases both of which share phenotypic features including airflow obstruction ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  8. Development of a genetic swine model of non alcoholic steatohepatitis NASH by gene editing

    Amount: $398,884.00

    PROJECT SUMMARY Nonalcoholic fatty liver disease NAFLD is the accumulation of fat in liver cells that advance to the more severe form called nonalcoholic steatohepatitis NASH characterized by inf ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  9. Development of a porcine model of polycystic kidney disease by multiplex gene-editing.

    Amount: $1,477,809.00

    PROJECT SUMMARY Polycystic kidney diseasesPKDare a group of inherited disorders characterized by progressive cyst development in the kidney resulting in bilateral renal enlargement and often end stage ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  10. Generating a Porcine Model for Human Microvillus Inclusion Disease (MVID) by Gene Editing

    Amount: $394,730.00

    DESCRIPTION provided by applicant Microvillus inclusion disease MVID is the most severe cause of Congenital Diarrheal Diseases in neonates MVID results from mutations that lead to malabsorption ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government